Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2006/12/01
-
Journal
-
Indian UGC (journal)
-
Refrences57
-
Citations419
-
Jacqueline Jonklaas Georgetown University Medical Center, Washington, D.C.
-
Nicholas J. Sarlis University of Texas M.D. Anderson Cancer Center, Houston, Texas.Present address: Sanofi-Aventis Pharmaceuticals, Bridgewater, New Jersey.
-
Danielle Litofsky University of Texas M.D. Anderson Cancer Center, Houston, Texas.
-
Kenneth B. Ain University of Kentucky Medical Center, Lexington, Kentucky.
-
S. Thomas Bigos Maine Medical Center, Portland, Maine.
-
James D. Brierley Princess Margaret Hospital, Toronto, Ontario, Canada.
-
David S. Cooper Sinai Hospital, Baltimore, Maryland.
-
Bryan R. Haugen University of Colorado at Denver and Health Sciences Center, Aurora, Colorado.
-
Paul W. Ladenson Johns Hopkins University School of Medicine, Baltimore, Maryland.
-
James Magner Genzyme Corporation, Cambridge, Massachusetts.
-
Jacob Robbins National Institutes of Health, Bethesda, Maryland.
-
Douglas S. Ross Massachusetts General Hospital, Boston, Massachusetts.
-
Monica Skarulis National Institutes of Health, Bethesda, Maryland.
-
Harry R. Maxon University of Cincinnati Medical Center, Cincinnati, Ohio.
-
Steven I. Sherman University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Cite
Jonklaas, Jacqueline, et al. “Outcomes of Patients With Differentiated Thyroid Carcinoma Following Initial Therapy”. Thyroid, vol. 16, no. 12, 2006, pp. 1229-42, https://doi.org/10.1089/thy.2006.16.1229.
Jonklaas, J., Sarlis, N. J., Litofsky, D., Ain, K. B., Bigos, S. T., Brierley, J. D., Cooper, D. S., Haugen, B. R., Ladenson, P. W., Magner, J., Robbins, J., Ross, D. S., Skarulis, M., Maxon, H. R., & Sherman, S. I. (2006). Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy. Thyroid, 16(12), 1229-1242. https://doi.org/10.1089/thy.2006.16.1229
Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, et al. Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy. Thyroid. 2006;16(12):1229-42.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the endocrine glands
Clinical endocrinology
Medicine
Internal medicine
Specialties of internal medicine
Nutritional diseases
Deficiency diseases
Science
Biology (General)
Science
Chemistry
Organic chemistry
Biochemistry
You May Also Like
- Bisphenol A: An endocrine and metabolic disruptor
- Human ovarian follicular development: From activation of resting follicles to preovulatory maturation
- Management of clinically non-functioning pituitary adenoma
- Epidemiology of Type 1 Diabetes
- The metabolic syndrome: prevalence in worldwide populations
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1200/JCO.1997.15.5.2067 | 1997 | |||
Histological Evaluation of Thyroid Carcinomas: Reproducibility of the «Who» Classification | Tumori Journal |
| 29 | 1993 |
| Histological Evaluation of Thyroid Carcinomas: Reproducibility of the «Who» Classification | Clinical Laboratory |
| 2003 | |
| Histological Evaluation of Thyroid Carcinomas: Reproducibility of the «Who» Classification | 2002 | |||
| Histological Evaluation of Thyroid Carcinomas: Reproducibility of the «Who» Classification | 1994 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Thyroid Cancer | JAMA |
| 3 | 2024 |
| A risk stratification system developed to predict contralateral incidental malignant foci in early papillary thyroid carcinoma preoperatively | The Surgeon |
| 2024 | |
Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study | Endocrinology and Metabolism |
| 1 | 2024 |
Chapter 7: Radioactive Iodine Treatment in Differentiated Thyroid Cancer | Journal of Head & Neck Physicians and Surgeons |
| 2024 | |
| Effect of thyroid-stimulating hormone suppression on quality of life in thyroid lobectomy patients: interim analysis of a multicenter, randomized controlled trial in low- to intermediate-risk thyroid cancer patients (MASTER study) | Annals of Surgical Treatment and Research |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 251
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma and was published in 2006. The most recent citation comes from a 2024 study titled Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study. This article reached its peak citation in 2014, with 38 citations. It has been cited in 172 different journals, 15% of which are open access. Among related journals, the Thyroid cited this research the most, with 40 citations. The chart below illustrates the annual citation trends for this article.